ClinicalTrials.govpublic full text
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
hepatocellular carcinoma, tace, carcinoma,hepatocellular, liver neoplasms, overall survival, recombinant human adenovirus type 5 injection, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909189
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.